Dose Range: 6001000 mcg total blend daily (300500 mcg of each peptide)
Hypertrophic AT secretes more matrix metalloproteinase 9, leading to elastin fiber and ECM degradation, thereby diminishing skin structural integrity and its ability to resist vertical gravitational vectors
Managing hypothyroidism and weight loss
Personalized medicine: Advances in pharmacogenomics may allow for more targeted use of GLP-1s, optimizing efficacy and minimizing side effects based on individual genetic profiles
Brooks SM et al
Complete medical history with obesity-specific focus Physical examination: BMI, waist circumference, blood pressure, thyroid palpation Laboratory studies: comprehensive metabolic panel, lipid panel, HbA1c, fasting insulin, TSH, calcitonin (if thyroid concerns), lipase Screening for eating disorders (particularly binge eating disorder and bulimia) Medication reconciliation to identify potential interactions Depression and suicidal ideation screening (PHQ-9) Semaglutide Dosing Schedules and Escalation Protocols Dosing is where semaglutide training for physicians has the most immediate clinical impact